Last reviewed · How we verify

NCT04835103

Build a Research Clinic for Somatoform Patients

Completed NA Last updated 20 January 2025
What this trial tests

NA trial testing CM in Somatoform Disorders in 1,000 participants. Completed in 14 March 2024.

Timeline
9 July 2021
Primary endpoint
24 January 2024
14 March 2024

Quick facts

Lead sponsorNational Taiwan University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment1,000
Start date9 July 2021
Primary completion24 January 2024
Estimated completion14 March 2024
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taiwan University Hospital

Who can join

Adults 15 to 80, any sex, with Somatoform Disorders or Somatic Symptom Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the effects of the two following interventions on somatoform patients:1. case management model2. psychotherapy, based on cognitive-behavioral therapy and biofeedback therapy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of CM

Trials testing the same drug.

Other National Taiwan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04835103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing